Fairfax Financial (FFH.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Fairfax Financial (FFH.TO)

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

2,220.71

+24.98 (1.14%)

as of Jun 5, 2026, 8:00:00 pm Market Open.

281 watching

Investor Insights

Jun 5, 2026, 12:00 am

This summary was created by AI, based on 23 opinions in the last 12 months.

Fairfax Financial (FFH) has garnered a mixture of perspectives from various experts, predominantly praising its long-term value focus and solid management under Prem Watsa. The company has shown excellent performance in its insurance business, with recent results indicating a strong combined ratio and improved underwriting metrics. However, several analysts caution against entering the stock at present due to the absence of immediate buying catalysts and its high valuation relative to peers. While some experts express ongoing confidence in FFH's long-term prospects, others suggest waiting for a more attractive entry point. Overall, the prevailing sentiment indicates FFH as a stable, defensive choice in the insurance sector, which has been resilient in recent market conditions.

Consensus

Hold

Valuation

Fair Value

Similar

BRK.A

COMMENT

It is a well-run company but it tends to make very big bets. More often than not, they get it right. Right now, we are in a difficult market environment to fundamentally see the right value. Generally, you want to be cautious. Over the long run, they should do well.

DON'T BUY

He prefers buying a insurance company directly like Manulife and Intact. Though well-run, FFH has a mixed bag of many assets. This mix adds a level of risk vs. pure insurers.

COMMENT

Good job growing book value. Multiple contracting, consolidation period. So something to look at. Hasn't done a ton of research on it.

DON'T BUY

It was a counter cyclical until they took all their losses and now have all these junky names that aren't doing that well, so it is pro-cyclical. He would stay away from it.

DON'T BUY

Some of the recent investments have been questionable and the stock has been underperforming for a while. It is probably at a deep discount compared to its book value. He has moved away from conglomerate insurance companies.

DON'T BUY

He thinks they failed on several fronts. Their insurance division faces interest rates that are zero or going negative. If we stay in a deflation world, it will be hell for them for the next several years. He sees no reason to own this right now.

BUY

It has wide swings with respect to its earnings profile. Its insurance operations have been fairly steady. You will see more volatility in the stock short term, yet there has been a lot of management buying of the stock. It is a very well managed company that will continue to do well.

WAIT

FFH buying BB? He thought the rumour of FFH buying BB created a lot of volume, which made him suspect. BB has a lot of automotive exposure, which hold back their recovery post-pandemic. BB has a cyber-security division that may lead to some opportunities.

DON'T BUY

The environment is so difficult for them. They are not making any money on the float. If it drops below $314, the market is questioning the viability of the balance sheet. The tide is going out. Put a stop in place.

DON'T BUY

Prem Watsa has been under fire lately. Their underlying insurance business will struggle under low interest rates to generate profits and income. Watsa's investments in the past decade have been dubious.

PAST TOP PICK

(A Top Pick Feb 05/19, Down 7%) He still likes it. It is a very well run company. Today their insurance business is as strong as it has ever been. They've been doing a good job monetizing some investments on the investment side of the business. It is trading at book but peers are trading at 1.5 times book.

PAST TOP PICK

(A Top Pick Sep 12/19, Up 2%) He still thinks Prem Watsa will deliver. FFH has a global reach and long-term commitment to India. $540-600 band is supportive, but he's looking for upside above $600-620. If so, this could go to $800.

DON'T BUY

Insurance and hedge businesses lead to some volatility in earnings. The chart doesn't show much, neutral, and doesn't indicate much opportunity. Can't see it going up or down. It's stuck in a range.

DON'T BUY

A catalyst? His model price is $571, so it is a little expensive here. The story is stale he thinks and expects it to continue to be range bound.

DON'T BUY

Three-year time horizon. He sold this, because it wasn't performing, failing to reach 2018 highs. Doesn't see a sign of that happening...yet. He's neutral on it, but look elsewhere.

Showing 91 to 105 of 455 entries

Most Recent Experts

Brian Madden

First Avenue Investment Counsel

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Darren Sissons

Campbell Lee & Ross

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Joe Terranova

Virtus Investment Partners

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Fairfax Financial (FFH.TO)